Valle García-Sánchez

1.7k total citations
42 papers, 818 citations indexed

About

Valle García-Sánchez is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Valle García-Sánchez has authored 42 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 24 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Valle García-Sánchez's work include Inflammatory Bowel Disease (30 papers), Microscopic Colitis (13 papers) and Celiac Disease Research and Management (5 papers). Valle García-Sánchez is often cited by papers focused on Inflammatory Bowel Disease (30 papers), Microscopic Colitis (13 papers) and Celiac Disease Research and Management (5 papers). Valle García-Sánchez collaborates with scholars based in Spain, Palestinian Territory and Bulgaria. Valle García-Sánchez's co-authors include Javier P. Gisbert, María Chaparro, Ignacio Marín‐Jiménez, Manuel Barreiro‐de Acosta, Luís Menchén, Carlos Taxonera, Albert Villòria, Daniel Ginard, José R. Villagrasa and Isabel González-Gascón-y-Marín and has published in prestigious journals such as Gastroenterology, International Journal of Molecular Sciences and The American Journal of Gastroenterology.

In The Last Decade

Valle García-Sánchez

40 papers receiving 799 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valle García-Sánchez Spain 15 538 511 201 167 84 42 818
Gary R Lichtenstein United States 4 589 1.1× 504 1.0× 265 1.3× 93 0.6× 51 0.6× 9 792
Garrett Lawlor United States 15 436 0.8× 481 0.9× 207 1.0× 107 0.6× 139 1.7× 48 908
Beatriz Sicilia Spain 14 501 0.9× 380 0.7× 369 1.8× 109 0.7× 77 0.9× 50 766
Manuela Marzo Italy 19 688 1.3× 600 1.2× 359 1.8× 254 1.5× 93 1.1× 46 1.1k
Luís Correia Portugal 14 509 0.9× 417 0.8× 220 1.1× 135 0.8× 37 0.4× 52 705
Camille Zallot France 12 600 1.1× 515 1.0× 295 1.5× 166 1.0× 107 1.3× 20 1.0k
J F Colombel United States 18 798 1.5× 621 1.2× 271 1.3× 128 0.8× 35 0.4× 69 1.0k
Peter Church Canada 17 637 1.2× 465 0.9× 334 1.7× 135 0.8× 24 0.3× 54 833
Tim Orchard United Kingdom 4 884 1.6× 638 1.2× 506 2.5× 144 0.9× 67 0.8× 11 1.2k
Gili Focht Israel 14 464 0.9× 316 0.6× 227 1.1× 80 0.5× 183 2.2× 53 694

Countries citing papers authored by Valle García-Sánchez

Since Specialization
Citations

This map shows the geographic impact of Valle García-Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valle García-Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valle García-Sánchez more than expected).

Fields of papers citing papers by Valle García-Sánchez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valle García-Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valle García-Sánchez. The network helps show where Valle García-Sánchez may publish in the future.

Co-authorship network of co-authors of Valle García-Sánchez

This figure shows the co-authorship network connecting the top 25 collaborators of Valle García-Sánchez. A scholar is included among the top collaborators of Valle García-Sánchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valle García-Sánchez. Valle García-Sánchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iglesias-Flores, E, J M Benítez, Beatriz Gros, et al.. (2023). Development of a Prediction Model for Short-Term Remission of Patients with Crohn’s Disease Treated with Anti-TNF Drugs. International Journal of Molecular Sciences. 24(10). 8695–8695. 1 indexed citations
2.
Zabana, Yamile, Julián Panés, Pilar Nos, et al.. (2020). The ENEIDA registry (Nationwide study on genetic and environmental determinants of inflammatory bowel disease) by GETECCU: Design, monitoring and functions. Gastroenterología y Hepatología (English Edition). 43(9). 551–558. 7 indexed citations
3.
Fernández‐Gutiérrez, Benjamín, Javier P. Gisbert, Eugeni Domènech, et al.. (2017). Cardiovascular disease in immune-mediated inflammatory diseases. Medicine. 96(26). e7308–e7308. 35 indexed citations
4.
Benítez, J M, et al.. (2017). Prevalencia de déficit de hierro sin anemia en la enfermedad inflamatoria intestinal y su impacto en la calidad de vida. Gastroenterología y Hepatología. 41(1). 22–29. 28 indexed citations
5.
González‐Romo, Fernando, J.J. Picazo, A Rojas, et al.. (2017). [Consensus document on pneumococcal vaccination in adults at risk by age and underlying clinical conditions. 2017 Update].. PubMed. 30(2). 142–168. 22 indexed citations
6.
Khorrami, Sam, Daniel Ginard, Ignacio Marín‐Jiménez, et al.. (2016). Ustekinumab for the Treatment of Refractory Crohnʼs Disease. Inflammatory Bowel Diseases. 22(7). 1662–1669. 124 indexed citations
7.
Castro-Laria, Luisa, Federico Argüelles‐Arias, Valle García-Sánchez, et al.. (2016). Initial experience with golimumab in clinical practice for ulcerative colitis. Revista Española de Enfermedades Digestivas. 108(3). 129–32. 12 indexed citations
8.
Hernández‐Breijo, Borja, María Chaparro, Iván Guerra, et al.. (2016). Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn’s disease patients treated with infliximab. Biochemical Pharmacology. 122. 33–41. 10 indexed citations
9.
Saro, Cristina, Daniel Ceballos, Fernándo Muñoz, et al.. (2016). Clinical status, quality of life, and work productivity in Crohns disease patients after one year of treatment with adalimumab. Revista Española de Enfermedades Digestivas. 109(2). 122–129. 6 indexed citations
10.
Chaparro, María, Jordi Gordillo, Eugeni Domènech, et al.. (2015). P438. Prospective, randomized clinical trial comparing the efficacy of two vaccines against hepatitis B virus (HBV) in inflammatory bowel disease (IBD) patients. Journal of Crohn s and Colitis. 9(suppl 1). S299–S299. 1 indexed citations
11.
Taxonera, Carlos, Manuel Barreiro‐de Acosta, Marta Calvo, et al.. (2015). Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis. Digestive Diseases and Sciences. 60(10). 3075–3084. 26 indexed citations
12.
Iglesias-Flores, E, et al.. (2015). Adherence to a predefined vaccination program in patients with inflammatory bowel disease. Gastroenterología y Hepatología. 39(6). 385–392. 7 indexed citations
13.
Chaparro, María, Jordi Gordillo, Eugeni Domènech, et al.. (2014). Mo1740 Prospective, Randomized Clinical Trial Comparing the Efficacy of Two Vaccines Against Hepatitis B Virus (HBV) in Inflammatory Bowel Disease (IBD) Patients. Gastroenterology. 146(5). S–648. 3 indexed citations
14.
Picazo, Juan J., Fernando González‐Romo, A Rojas, et al.. (2013). Consenso sobre la vacunación anti-neumocócica en el adulto con patología de base ◊, ∆. Revista española de quimioterapia. Suplemento. 26(3). 232–252. 29 indexed citations
15.
Acosta, Manuel Barreiro‐de, et al.. (2013). Enterocutaneous fistulas and Crohn's disease: Clinical characteristics and response to treatment. Revista Española de Enfermedades Digestivas. 105(1). 3–6. 12 indexed citations
16.
Ginard, Daniel, Sam Khorrami, Ignacio Marı́n, et al.. (2013). P425 One-year outcomes of ustekinumab therapy in a multi-drug refractory Crohn's disease cohort. Journal of Crohn s and Colitis. 7. S180–S180. 4 indexed citations
17.
Gisbert, Javier P., Luís Menchén, Valle García-Sánchez, et al.. (2012). Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 35(12). 1379–1385. 69 indexed citations
18.
García‐Bosch, Orlando, Míriam Mañosa, Valle García-Sánchez, et al.. (2011). Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: A multicenter study. Inflammatory Bowel Diseases. 18(5). 812–817. 69 indexed citations
19.
Rodríguez‐Perálvarez, Manuel, et al.. (2011). Radio induced cancer risk during ERCP: Is it a real clinical problem?. Revista Española de Enfermedades Digestivas. 103(4). 191–195. 14 indexed citations
20.
Sánchez‐García, Joaquín, et al.. (2010). Tumor necrosis factor‐α‐secreting CD16+ antigen presenting cells are effectively removed by granulocytapheresis in ulcerative colitis patients. Journal of Gastroenterology and Hepatology. 25(12). 1869–1875. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026